Bohm J | Seppälä Labhttps://www.seppalalab.org/author/bohm-j/Bohm JHugo Blox Builder (https://hugoblox.com)enThu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.pngBohm Jhttps://www.seppalalab.org/author/bohm-j/Distance-based evaluation of tumor budding in colorectal cancerhttps://www.seppalalab.org/publication/aijala-2026-distance-based/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/aijala-2026-distance-based/Impact of stromal maturity and proportion on prognosis and immune landscape in colorectal cancerhttps://www.seppalalab.org/publication/tapiainen-2026-impact/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/tapiainen-2026-impact/MLH1 Lynch Syndrome Colorectal Cancers Are Driven by Heterogeneous Wnt Pathway Gene Mutationshttps://www.seppalalab.org/publication/hokkanen-2026-mlh1/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/hokkanen-2026-mlh1/Nanopore sequencing reveals hidden landscape of short L1 transductions in colorectal cancerhttps://www.seppalalab.org/publication/nummi-2026-nanopore/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/nummi-2026-nanopore/NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndromehttps://www.seppalalab.org/publication/de-2026-nous-209/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/de-2026-nous-209/Quantitative analysis of myeloid cell patterns and immunosuppressive enzyme (IDO, ARG1) expression in colorectal cancer pulmonary metastases and corresponding primary tumourshttps://www.seppalalab.org/publication/karjula-2026-quantitative/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/karjula-2026-quantitative/Significance of tumor infiltrating granulocytes and neutrophil extracellular traps in colorectal cancerhttps://www.seppalalab.org/publication/rahkola-2026-significance/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/rahkola-2026-significance/Tumour immune contexture and immune evasion in sporadic and Lynch syndrome-associated microsatellite unstable colorectal cancershttps://www.seppalalab.org/publication/martin-2026-tumour/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/martin-2026-tumour/Unraveling the Effects and Characteristics of Proliferating Tumor and Cytotoxic T Cells in Colorectal Cancerhttps://www.seppalalab.org/publication/kastinen-2026-unraveling/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/kastinen-2026-unraveling/Urothelium marker UPK2 identifies aggressive colorectal cancers with distinct molecular and histological featureshttps://www.seppalalab.org/publication/aijala-2026-urothelium/Thu, 01 Jan 2026 00:00:00 +0000https://www.seppalalab.org/publication/aijala-2026-urothelium/Associations of mucinous differentiation and mucin expression with immune cell infiltration and prognosis in colorectal adenocarcinomahttps://www.seppalalab.org/publication/elomaa-2025-associations/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/elomaa-2025-associations/CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancerhttps://www.seppalalab.org/publication/sirnio-2025-cdx2/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/sirnio-2025-cdx2/Characteristics and significance of gammadelta T cells in colorectal cancerhttps://www.seppalalab.org/publication/karjalainen-2025-characteristics/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/karjalainen-2025-characteristics/Colorectal cancer heterogeneity co-evolves with tumor architecture to determine disease outcomehttps://www.seppalalab.org/publication/bertillot-2025-colorectal/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/bertillot-2025-colorectal/Comprehensive characterization of micropapillary colorectal adenocarcinomahttps://www.seppalalab.org/publication/aijala-2025-comprehensive/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/aijala-2025-comprehensive/Comprehensive metabolomic and epigenomic characterization of microsatellite stable BRAF-mutated colorectal cancerhttps://www.seppalalab.org/publication/taira-2025-comprehensive/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/taira-2025-comprehensive/Integrating Tumor Intraepithelial CD8(+) and Stromal FOXP3(+) T-Cell Densities as an Enhanced Immune Prognostic Index in Colorectal Cancerhttps://www.seppalalab.org/publication/tuomisto-2025-integrating/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/tuomisto-2025-integrating/Multimarker Assessment of B-Cell and Plasma Cell Subsets and Their Prognostic Role in the Colorectal Cancer Microenvironmenthttps://www.seppalalab.org/publication/sirkia-2025-multimarker/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/sirkia-2025-multimarker/Prognostic Features and Potential for Immune Therapy in Metastatic Mismatch Repair-Deficient Colorectal Cancer: A Retrospective Analysis of a Large Consecutive Population-Based Patient Serieshttps://www.seppalalab.org/publication/wirta-2025-prognostic/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/wirta-2025-prognostic/PTEN status, tumor immune microenvironment, and survival in colorectal cancerhttps://www.seppalalab.org/publication/karjalainen-2025-pten/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/karjalainen-2025-pten/Significance of mucin-suspended tumor bud-like structures in colorectal cancerhttps://www.seppalalab.org/publication/aijala-2025-significance/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/aijala-2025-significance/Significance of Th1 and Th2 Cell Densities and Th1/Th2 Cytokine Profiles in Colorectal Cancerhttps://www.seppalalab.org/publication/ojanpera-2025-significance/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/ojanpera-2025-significance/Stroma AReactive Invasion Front Areas (SARIFA), tumour immune microenvironment, and survival in colorectal cancerhttps://www.seppalalab.org/publication/tapiainen-2025-stroma/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/tapiainen-2025-stroma/Structural features of somatic and germline retrotransposition events in humanshttps://www.seppalalab.org/publication/nummi-2025-structural/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/nummi-2025-structural/Establishing Criteria for Tumor Necrosis as Prognostic Indicator in Colorectal Cancerhttps://www.seppalalab.org/publication/kastinen-2024-establishing/Mon, 01 Jan 2024 00:00:00 +0000https://www.seppalalab.org/publication/kastinen-2024-establishing/High immune cell infiltration predicts improved survival in cholangiocarcinomahttps://www.seppalalab.org/publication/wirta-2024-high/Mon, 01 Jan 2024 00:00:00 +0000https://www.seppalalab.org/publication/wirta-2024-high/Multiplexed analysis of macrophage polarisation in pulmonary metastases of microsatellite stable colorectal cancerhttps://www.seppalalab.org/publication/karjula-2024-multiplexed/Mon, 01 Jan 2024 00:00:00 +0000https://www.seppalalab.org/publication/karjula-2024-multiplexed/Quantitative Multiplexed Analysis of Indoleamine 2,3-Dioxygenase (IDO) and Arginase-1 (ARG1) Expression and Myeloid Cell Infiltration in Colorectal Cancerhttps://www.seppalalab.org/publication/elomaa-2024-quantitative/Mon, 01 Jan 2024 00:00:00 +0000https://www.seppalalab.org/publication/elomaa-2024-quantitative/The impact of preoperative treatments on the immune environment of rectal cancerhttps://www.seppalalab.org/publication/wirta-2024-the/Mon, 01 Jan 2024 00:00:00 +0000https://www.seppalalab.org/publication/wirta-2024-the/Immunological and prognostic significance of tumour necrosis in colorectal cancerhttps://www.seppalalab.org/publication/kastinen-2023-immunological/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/kastinen-2023-immunological/Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancerhttps://www.seppalalab.org/publication/elomaa-2023-spatially/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/elomaa-2023-spatially/Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancerhttps://www.seppalalab.org/publication/elomaa-2022-prognostic/Sat, 01 Jan 2022 00:00:00 +0000https://www.seppalalab.org/publication/elomaa-2022-prognostic/Distinct Mutational Profile of Lynch Syndrome Colorectal Cancers Diagnosed under Regular Colonoscopy Surveillancehttps://www.seppalalab.org/publication/ahadova-2021-distinct/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/ahadova-2021-distinct/Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancerhttps://www.seppalalab.org/publication/rajamaki-2021-genetic/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/rajamaki-2021-genetic/Prognostic Value of Immune Environment Analysis in Small Bowel Adenocarcinomas with Verified Mutational Landscape and Predisposing Conditionshttps://www.seppalalab.org/publication/wirta-2020-prognostic/Wed, 01 Jan 2020 00:00:00 +0000https://www.seppalalab.org/publication/wirta-2020-prognostic/Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancershttps://www.seppalalab.org/publication/hanninen-2019-exome/Tue, 01 Jan 2019 00:00:00 +0000https://www.seppalalab.org/publication/hanninen-2019-exome/